Skip to main content
. 2003 Mar 18;88(6):933–936. doi: 10.1038/sj.bjc.6600839

Table 1. Associations between CYP17 genotype and male breast cancer according to BRCA2 status.

  TT TC CC
All      
 Cases, n (%) 12 (30.8) 18 (46.1) 9 (23.1)
 Controls, n (%) 103 (33.3) 160 (51.8) 46 (14.9)
 OR (95% Cl) 1.0 0.97 (0.45–2.09) 1.68 (0.66–4.26)
BRCA2 status of cases      
 999del5, n (%) 4 (26.7) 6 (40.0) 5 (33.3)
 wt, n (%) 8 (33.3) 12 (50.0) 4 (16.7)
 OR (95% Cl) 1.0 1.00 (0.21–4.71) 2.50 (0.42–14.84)